Galenica AG (GALN.S)
GALN.S on Swiss Exchange
710.00CHF
31 Jul 2013
710.00CHF
31 Jul 2013
Price Change (% chg)
CHF20.00 (+2.90%)
CHF20.00 (+2.90%)
Prev Close
CHF687.50
CHF687.50
Open
CHF694.00
CHF694.00
Day's High
CHF714.00
CHF714.00
Day's Low
CHF692.50
CHF692.50
Volume
56,632
56,632
Avg. Vol
21,441
21,441
52-wk High
CHF714.00
CHF714.00
52-wk Low
CHF479.25
CHF479.25
About
Galenica AG is a Swiss holding company active in the healthcare market. It focuses on two business divisions: Pharma, mainly active in the iron deficiency anemia as well as consumer healthcare area; and Sante, combining products from Retail business sector, Logistics and Information management. The Company divides its activities... (more)
Overall
| Beta: | 0.63 |
| Market Cap (Mil.): | CHF4,615.00 |
| Shares Outstanding (Mil.): | 6.50 |
| Dividend: | 11.00 |
| Yield (%): | 1.55 |
Financials
| GALN.S | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | 18.19 | 17.21 | 39.77 |
| EPS (TTM): | 39.04 | -- | -- |
| ROI: | 12.39 | 10.01 | 66.51 |
| ROE: | 20.26 | 11.35 | 72.84 |
Galenica shares leap after U.S. approval for anaemia drug
ZURICH, July 26 - Shares in Swiss healthcare company Galenica climbed by more than 8 percent after it announced on Friday that U.S. healthcare regulators had approved its iron deficiency treatment Injectafer.
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: Datamonitor
|
$175.00
|
|
Provider: GlobalData
|
$125.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

